Medicare Enrolled
Dr. Swetha Yadav, MD
Hematology · Spring, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Yadav from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yadav?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Yadav
Dr. Swetha Yadav is a hematology specialist in Spring, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Yadav performed 4,662 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Yadav received a total of $6,936 from 50 pharmaceutical and/or device companies across 338 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Yadav is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 9% volume in TX
$6,936 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗4,662
Medicare services
Top 9% in TX for hematology
Not available
Unique patients (not deduplicated)
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 1,690 | $2 | $24 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
686 | $97 | $199 |
| Injection, granisetron hydrochloride, 100 mcg | 380 | $0 | $2 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
328 | $23 | $80 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
224 | $1 | $5 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
221 | $16 | $55 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
211 | $51 | $150 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
205 | $95 | $160 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
204 | $1 | $25 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
130 | $73 | $178 |
| Iron dextran injection, 50 mg An injection containing 50 mg of iron dextran administered to the patient. |
80 | $11 | $25 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
67 | $23 | $200 |
| New patient office visit, complex (60-74 min) | 57 | $159 | $310 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
53 | $106 | $350 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
41 | $64 | $160 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
33 | $138 | $360 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
26 | $61 | $120 |
| Advance care planning, each additional 30 minutes This code covers each additional 30 minutes spent on advance care planning discussions beyond the initial session. It involves counseling patients and families about future healthcare preferences and end-of-life care options. |
26 | $57 | $140 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
21.8% high complexity
52.4% medium
25.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,936
Total received (2019-2024)
Avg $1,156/year across 6 years
Top 33% in TX for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
338
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,576
2023
$1,701
2022
$1,642
2021
$1,130
2020
$639
2019
$249
Payments by company (2024)
Daiichi Sankyo Inc.
$255
SOBI, INC
$201
Novartis Pharmaceuticals Corporation
$201
AstraZeneca Pharmaceuticals LP
$160
Eisai Inc.
$109
E.R. Squibb & Sons, L.L.C.
$105
TAIHO ONCOLOGY, INC.
$77
PharmaEssentia USA Corporation
$57
Kite Pharma, Inc.
$56
Merck Sharp & Dohme LLC
$55
Alexion Pharmaceuticals, Inc.
$53
GlaxoSmithKline, LLC.
$38
PFIZER INC.
$37
ABBVIE INC.
$27
Aveo Pharmaceuticals, Inc.
$24
Janssen Pharmaceuticals, Inc
$24
PUMA BIOTECHNOLOGY, INC.
$23
Gilead Sciences, Inc.
$20
Incyte Corporation
$20
Azurity Pharmaceuticals, Inc.
$19
Rigel Pharmaceuticals, Inc.
$16
Top 3 companies account for 41.7% of 2024 payments
All-time payments by company (2019-2024) ›
E.R. Squibb & Sons, L.L.C.
$707
Novartis Pharmaceuticals Corporation
$686
AstraZeneca Pharmaceuticals LP
$541
AVEO Pharmaceuticals, Inc.
$452
Daiichi Sankyo Inc.
$423
PFIZER INC.
$414
Amgen Inc.
$375
Celgene Corporation
$271
SOBI, INC
$238
GlaxoSmithKline, LLC.
$197
Incyte Corporation
$190
PharmaEssentia USA Corporation
$180
Merck Sharp & Dohme LLC
$170
TAIHO ONCOLOGY, INC.
$167
Janssen Biotech, Inc.
$166
Eisai Inc.
$147
Janssen Pharmaceuticals, Inc
$139
TerSera Therapeutics LLC
$138
Alexion Pharmaceuticals, Inc.
$136
CTI BioPharma Corp.
$111
Merck Sharp & Dohme Corporation
$100
Mirati Therapeutics, Inc.
$91
Pharmacosmos Therapeutics Inc.
$86
Kite Pharma, Inc.
$70
Aveo Pharmaceuticals, Inc.
$63
Taiho Oncology, Inc.
$61
Dova Pharmaceuticals
$60
Ipsen Biopharmaceuticals, Inc
$58
Exelixis Inc.
$43
Gilead Sciences, Inc.
$42
Pharmacyclics LLC, an AbbVie Company
$36
EMD Serono, Inc.
$34
Blueprint Medicines Corporation
$27
ABBVIE INC.
$27
Genentech USA, Inc.
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$25
PUMA BIOTECHNOLOGY, INC.
$23
EISAI INC.
$20
Teva Pharmaceuticals USA, Inc.
$20
Azurity Pharmaceuticals, Inc.
$19
GENZYME CORPORATION
$19
Sobi, Inc
$18
Puma Biotechnology, Inc.
$18
Amneal Pharmaceuticals LLC
$17
MorphoSys, US Inc.
$16
Rigel Pharmaceuticals, Inc.
$16
Kyowa Kirin, Inc.
$15
Pharmacyclics LLC, An AbbVie Company
$14
ARRAY BIOPHARMA INC
$13
IBSA Pharma Inc.
$12
Top 3 companies account for 27.9% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · AVASTIN · Alecensa · BESREMI · BLENREP · BOSULIF · BRAFTOVI · Bavencio · CALQUENCE · Cabometyx · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ENHERTU · Enhertu · FOTIVDA · Fabhalta · GAVRETO · GILOTRIF · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LOKELMA · LONSURF · LUMAKRAS · Lenvima · Lonsurf · MONJUVI · MYLOTARG · Monoferric · NERLYNX · Nplate · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · PIQRAY · PROMACTA · Pomalyst · Quzyttir · REBLOZYL · RYBREVANT · Rezlidhia · SANCUSO · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SYNAGIS · TABRECTA · TASIGNA · Tirosint · Trodelvy · Truxima · ULTOMIRIS · VIVIMUSTA · VONJO · Vonjo · XALKORI · XARELTO · XGEVA · Xermelo · Yescarta · ZEJULA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
2
County median income
$97,266
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST THE WOODLANDS HOSPITAL
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Yadav is a clinical cardiology specialist, with above-average Medicare volume (top 9% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Yadav experienced with injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg?
Based on Medicare claims data, Dr. Yadav performed 1,690 injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Yadav receive payments from pharmaceutical companies?
Yes. Dr. Yadav received a total of $6,936 from 50 companies across 338 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yadav's costs compare to other hematologists in Spring?
Dr. Yadav's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yadav) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Spring
Browse hematologists in Spring ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in TX
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in TX
Which TX hematologists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology